Milestone Pharmaceuticals Inc Net Asset Quality Index
Milestone Pharmaceuticals Inc net asset quality index. Milestone Pharmaceuticals Inc (MIST) has a Net Asset Quality Index of 23.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $87.75 Million minus total liabilities of $67.25 Million yields net assets of $20.50 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Milestone Pharmaceuticals Inc (MIST) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Milestone Pharmaceuticals Inc (2017–2024)
Net asset quality index of Milestone Pharmaceuticals Inc from 2017 to 2024. This chart shows how Milestone Pharmaceuticals Inc's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 23.4%, representing net assets of $20.50 Million against total assets of $87.75 Million USD. Check Milestone Pharmaceuticals Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Milestone Pharmaceuticals Inc Net Asset Quality Index by Year (2017–2024)
Milestone Pharmaceuticals Inc net asset quality index by year from 2017 to 2024. The table below presents the year-by-year Net Asset Quality Index for Milestone Pharmaceuticals Inc from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Milestone Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 17.4% | $13.15 Million | $75.50 Million | $62.35 Million | ▼ -4.9 pp |
| 2023 | 22.3% | $16.77 Million | $75.23 Million | $58.45 Million | ▼ -66.8 pp |
| 2022 | 89.1% | $66.35 Million | $74.48 Million | $8.13 Million | ▼ -4.9 pp |
| 2021 | 94.0% | $112.60 Million | $119.85 Million | $7.25 Million | ▼ -1.5 pp |
| 2020 | 95.4% | $143.12 Million | $149.97 Million | $6.86 Million | ▲ +2.3 pp |
| 2019 | 93.1% | $114.92 Million | $123.43 Million | $8.51 Million | ▲ +155.8 pp |
| 2018 | -62.7% | $-55.21 Million | $88.08 Million | $143.29 Million | ▲ +57.4 pp |
| 2017 | -120.0% | $-33.12 Million | $27.59 Million | $60.71 Million | — |